Your browser doesn't support javascript.
loading
Reversal of Cisplatin Resistance in Ovarian Cancer by the Multitargeted Nanodrug Delivery System Tf-Mn-MOF@Nira@CDDP.
Liu, Yuan; Wang, Yiru; Guan, Xue; Wu, Qiong; Zhang, Mengjun; Cui, Ping; Wang, Can; Chen, Xiuwei; Meng, Xianwei; Ma, Tengchuang.
Affiliation
  • Liu Y; Department of Gynecology, Harbin Medical University Cancer Hospital, Nangang District, Harbin, Heilongjiang Province 150086, P.R. China.
  • Wang Y; Department of Gynecology, Harbin Medical University Cancer Hospital, Nangang District, Harbin, Heilongjiang Province 150086, P.R. China.
  • Guan X; Animal Laboratory Center, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province 150086, P.R. China.
  • Wu Q; Laboratory of Controllable Preparation and Application of Nanomaterials, Key Laboratory of Cryogenics, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, No. 29 East Road Zhongguancun, Beijing 100190, P.R. China.
  • Zhang M; Department of Gynecology, Harbin Medical University Cancer Hospital, Nangang District, Harbin, Heilongjiang Province 150086, P.R. China.
  • Cui P; Department of Gynecology, Harbin Medical University Cancer Hospital, Nangang District, Harbin, Heilongjiang Province 150086, P.R. China.
  • Wang C; Department of Gynecology, Harbin Medical University Cancer Hospital, Nangang District, Harbin, Heilongjiang Province 150086, P.R. China.
  • Chen X; Department of Gynecology, Harbin Medical University Cancer Hospital, Nangang District, Harbin, Heilongjiang Province 150086, P.R. China.
  • Meng X; Laboratory of Controllable Preparation and Application of Nanomaterials, Key Laboratory of Cryogenics, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, No. 29 East Road Zhongguancun, Beijing 100190, P.R. China.
  • Ma T; Department of Nuclear Medicine, Harbin Medical University Cancer Hospital, Nangang District, Harbin, Heilongjiang Province 150086, P.R. China.
ACS Appl Mater Interfaces ; 15(22): 26484-26495, 2023 Jun 07.
Article de En | MEDLINE | ID: mdl-37218712
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire / Nanoparticules / Antinéoplasiques Limites: Animals / Female / Humans Langue: En Journal: ACS Appl Mater Interfaces Sujet du journal: BIOTECNOLOGIA / ENGENHARIA BIOMEDICA Année: 2023 Type de document: Article Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire / Nanoparticules / Antinéoplasiques Limites: Animals / Female / Humans Langue: En Journal: ACS Appl Mater Interfaces Sujet du journal: BIOTECNOLOGIA / ENGENHARIA BIOMEDICA Année: 2023 Type de document: Article Pays de publication: États-Unis d'Amérique